Category: Press Release - Part 4

Princeton, NJ – November 4, 2002 – Laureate Pharma L.P. announced the appointment of John J. Morris as Vice President, Controller & Strategic Planning. Reporting to Robert J. Broeze, Ph.D., President, he is responsible for all aspects of finance, supply chain management, information technology, and corporate planning. “It is my privilege to welcome John to our management team”, said Robert J. Broeze, Ph.D., President of Laureate Pharma L.P. “His impressive…

Princeton, NJ, October 17, 2002 /PRNewswire/ – Laureate Pharma L.P. today announced the appointment of F. Peter Boer, Ph.D. as a new member of its Board of Directors. Dr. Boer is President and CEO of Tiger Scientific Inc., a firm providing consulting and investment services in the technology arena. In addition, Dr. Boer is the John J. Lee Adjunct Professor at Yale University, where he teaches environmental engineering in the…

PRINCETON, N.J. and BIRMINGHAM, Ala., Sept. 10, 2002 /PRNewswire/ — Laureate Pharma L.P. and Southern Research Institute announced today the initiation of a strategic collaboration agreement related to developing and manufacturing drug-delivery products using Southern Research’s proprietary microencapsulation process technologies. Under the agreement, Laureate Pharma and Southern Research will collaborate to provide pharmaceutical clients with full microencapsulation services that range from development through commercial scale manufacturing. Terms of the agreement…

PRINCETON, NJ – August 20, 2002 – Laureate Pharma L.P. and TolerRx, Inc. announce the initiation of a biopharmaceutical manufacturing and services agreement for TolerRx’s therapeutic monoclonal antibody pipeline. Under the contract, Laureate Pharma will provide purification and aseptic filling services to support TolerRx’s clinical trials. Terms of the agreement were not disclosed. “We believe there is an excellent fit between our expertise in development and manufacturing of biopharmaceuticals and…

Princeton, NJ – June 24, 2002 – Laureate Pharma L.P. and DrugAbuse Sciences, Inc. announce the initiation of a contract manufacturing agreement related to a sustained release microsphere product. Under the agreement, Laureate Pharma will provide manufacturing services for DrugAbuse Sciences’ Naltrexone Depot product, currently in clinical trials. Terms of the agreement were not disclosed. “We are very excited about this agreement and look forward to building a long term…

Company offers services for development and manufacture of biopharmaceuticals and sustained-release products Princeton, NJ – May 21, 2002 – Laureate Pharma Company announces the launch of contract manufacturing services at its two sites in New Jersey. Biopharmaceutical development and manufacturing services will be provided at a cGMP manufacturing facility in Princeton, NJ. Services related to sustained release microsphere products will be provided at its second manufacturing site in Totowa, NJ….